Immune therapy tested for kids with Sudden-Onset OCD and eating fears

NCT ID NCT04609761

Summary

This study tested whether a treatment called intravenous immunoglobulin (IVIG) could help children with Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), a condition where kids suddenly develop severe obsessive-compulsive behaviors or food refusal. Ten children aged 4-17 received monthly IVIG infusions for six months. Researchers measured changes in symptoms, school attendance, and quality of life to see if this immune-based therapy was safe and effective.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANS PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Gillberg Neuropsychiatry Centre

    Gothenburg, 411 19, Sweden

Conditions

Explore the condition pages connected to this study.